- Home
- IMUX vs YGMZ Comparison
IMUX vs YGMZ Comparison
Compare IMUX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- YGMZ
- Stock Information
- Founded
- IMUX 2016
- YGMZ 2002
- Country
- IMUX United States
- YGMZ China
- Employees
- IMUX N/A
- YGMZ N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- YGMZ Transportation Services
- Sector
- IMUX Health Care
- YGMZ Consumer Discretionary
- Exchange
- IMUX Nasdaq
- YGMZ Nasdaq
- Market Cap
- IMUX 107.3M
- YGMZ 101.2M
- IPO Year
- IMUX N/A
- YGMZ 2020
- Fundamental
- Price
- IMUX $0.70
- YGMZ $1.28
- Analyst Decision
- IMUX Strong Buy
- YGMZ
- Analyst Count
- IMUX 6
- YGMZ 0
- Target Price
- IMUX $11.60
- YGMZ N/A
- AVG Volume (30 Days)
- IMUX 1.4M
- YGMZ 18.4K
- Earning Date
- IMUX 05-15-2025
- YGMZ 01-01-0001
- Dividend Yield
- IMUX N/A
- YGMZ N/A
- EPS Growth
- IMUX N/A
- YGMZ N/A
- EPS
- IMUX N/A
- YGMZ N/A
- Revenue
- IMUX N/A
- YGMZ $40,429,750.00
- Revenue This Year
- IMUX N/A
- YGMZ N/A
- Revenue Next Year
- IMUX N/A
- YGMZ N/A
- P/E Ratio
- IMUX N/A
- YGMZ N/A
- Revenue Growth
- IMUX N/A
- YGMZ N/A
- 52 Week Low
- IMUX $0.56
- YGMZ $0.64
- 52 Week High
- IMUX $2.11
- YGMZ $4.35
- Technical
- Relative Strength Index (RSI)
- IMUX 31.04
- YGMZ 51.47
- Support Level
- IMUX $0.56
- YGMZ $1.22
- Resistance Level
- IMUX $0.95
- YGMZ $1.44
- Average True Range (ATR)
- IMUX 0.07
- YGMZ 0.10
- MACD
- IMUX -0.03
- YGMZ -0.03
- Stochastic Oscillator
- IMUX 30.28
- YGMZ 23.53
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.